Shikhar Mehrotra to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Shikhar Mehrotra has written about Xenograft Model Antitumor Assays.
Connection Strength
0.735
-
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res. 2019 02 01; 25(3):1036-1049.
Score: 0.619
-
Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo. Ann Surg Oncol. 2019 Dec; 26(13):4782-4790.
Score: 0.041
-
ER stress-induced mediator C/EBP homologous protein thwarts effector T?cell activity in tumors through T-bet repression. Nat Commun. 2019 03 20; 10(1):1280.
Score: 0.040
-
Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset. Oncotarget. 2017 May 02; 8(18):30199-30216.
Score: 0.035